Shedir Pharma Group Balance Sheet Health
Financial Health criteria checks 5/6
Shedir Pharma Group has a total shareholder equity of €36.1M and total debt of €4.7M, which brings its debt-to-equity ratio to 13.1%. Its total assets and total liabilities are €56.1M and €20.0M respectively. Shedir Pharma Group's EBIT is €8.4M making its interest coverage ratio 28.6. It has cash and short-term investments of €1.2M.
Key information
13.1%
Debt to equity ratio
€4.74m
Debt
Interest coverage ratio | 28.6x |
Cash | €1.23m |
Equity | €36.10m |
Total liabilities | €20.03m |
Total assets | €56.13m |
Recent financial health updates
Recent updates
Shedir Pharma Group's (BIT:SHE) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 05Why Shedir Pharma Group's (BIT:SHE) Earnings Are Better Than They Seem
Oct 05Is Shedir Pharma Group (BIT:SHE) Using Too Much Debt?
Apr 06What Type Of Returns Would Shedir Pharma Group's(BIT:SHE) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Dec 30Financial Position Analysis
Short Term Liabilities: SHE's short term assets (€41.9M) exceed its short term liabilities (€14.4M).
Long Term Liabilities: SHE's short term assets (€41.9M) exceed its long term liabilities (€5.6M).
Debt to Equity History and Analysis
Debt Level: SHE's net debt to equity ratio (9.7%) is considered satisfactory.
Reducing Debt: SHE's debt to equity ratio has reduced from 62.1% to 13.1% over the past 5 years.
Debt Coverage: SHE's debt is not well covered by operating cash flow (12.6%).
Interest Coverage: SHE's interest payments on its debt are well covered by EBIT (28.6x coverage).